Denise Cristiana Faro | Cardiology | Best Researcher Award

Dr. Denise Cristiana Faro | Cardiology | Best Researcher Award

University of Catania | Italy

Dr. Denise Cristiana Faro is a dedicated Medical Doctor, Cardiovascular Specialist, and PhD candidate at the University of Catania, whose academic and clinical career centers on advancing the understanding and management of rare cardiomyopathies, with a primary focus on Anderson-Fabry disease and transthyretin cardiac amyloidosis. She has established herself as an emerging leader in translational cardiology by integrating advanced echocardiographic imaging, genetics, and sex-specific approaches into her research, aiming to enhance early diagnosis, risk stratification, and tailored therapeutic strategies. With 22 published documents, 366 citations across 310 documents, and an h-index of 11, her scholarly contributions reflect both depth and growing international recognition. As co-investigator and sub-investigator in numerous multicenter clinical studies and registries, she has collaborated on cutting-edge projects addressing arrhythmic risk, disease biomarkers, wearable device applications, and therapeutic outcomes in Fabry disease and cardiac amyloidosis. Beyond research, Dr. Faro contributes to academic growth through teaching, peer review for high-impact cardiovascular journals, and authorship of book chapters, including Cardioncologia by the Italian Society of Cardiology. Her active memberships in multiple working groups of the European Society of Cardiology and the Italian Society of Cardiology further highlight her role in shaping multidisciplinary and personalized approaches in cardiovascular medicine.

Profiles: Scopus | Orcid

Featured Publications

Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis

Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology

Comparison of personality and psychopathology in patients with Fabry disease and patients with end-stage renal disease: a preliminary study

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects

Assessment of Noninferiority Margins in Cardiovascular Medicine Trials